GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stimcell Energetics Inc (OTCPK:STME) » Definitions » 3-Year ROIIC %

STME (Stimcell Energetics) 3-Year ROIIC % : 3,772.73% (As of May. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Stimcell Energetics 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Stimcell Energetics's 3-Year ROIIC % for the quarter that ended in May. 2024 was 3,772.73%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Stimcell Energetics's 3-Year ROIIC % or its related term are showing as below:

STME's 3-Year ROIIC % is ranked better than
99.27% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 0.02 vs STME: 3772.73

Stimcell Energetics 3-Year ROIIC % Historical Data

The historical data trend for Stimcell Energetics's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stimcell Energetics 3-Year ROIIC % Chart

Stimcell Energetics Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -64.77 636.57 0.98 118.95 3,772.73

Stimcell Energetics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 3,772.73 - -

Competitive Comparison of Stimcell Energetics's 3-Year ROIIC %

For the Medical Devices subindustry, Stimcell Energetics's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stimcell Energetics's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's 3-Year ROIIC % falls into.



Stimcell Energetics 3-Year ROIIC % Calculation

Stimcell Energetics's 3-Year ROIIC % for the quarter that ended in May. 2024 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -0.268 (May. 2024) - -0.683 (May. 2021) )/( 0.314 (May. 2024) - 0.303 (May. 2021) )
=0.415/0.011
=3,772.73%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Stimcell Energetics  (OTCPK:STME) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Stimcell Energetics 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Stimcell Energetics's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stimcell Energetics Business Description

Traded in Other Exchanges
N/A
Address
1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Stimcell Energetics Inc is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to: aging, diabetes, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
Executives
Richard Jeffs 10 percent owner FLAT 7, 6 ENNISMORE GARDENS, LONDON X0 SW7 1NL
Dwayne Yaretz director, officer: Chief Executive Officer SUITE 1050 WEST PENDER STREET SUITE 2250, VANCOUVER A1 V6E 3S7
Bradley S Hargreaves 10 percent owner 904-1616 BAYSHORE DR, VANCOUVER A1 V6G3L1
Frank Mcenulty director, officer: CEO, CFO, Treas., Sec 4182 N. VIKING WAY, SUITE 216, LONG BEACH CA 90808-1475
Joao Dacosta director, officer: COO #810 - 789 WEST PENDER STREET, VANCOUVER A1 V6C 1H2
George Adams director 7535 CONSERVATION ROAD, GUELPH A6 N1H6J1
Terrance George Owen director, officer: CEO 635 FOURTH LINE (UNIT 1), OAKVILLE A6 L6L 5BO
John David Sanderson officer: Chief Medical Officer 9 ISLANDVIEW, IRVINE CA 92604
Yanika S Silina officer: CFO, Treasurer and Secretary 789 WEST PENDER STREET, UNIT 810, VANCOUVER A1 V6C 1H2
Jean M Arnett 10 percent owner 121 - 3989 HENNING DRIVE, BURNABY A1 V5C 6P8
Ean Kremer director, officer: Chief Technology Officer C/O PLANDEL RESOURCES, INC., 4575 DEAN MARTIN DRIVE, STE. 2206, LAS VEGAS NV 89103